• Episode 103: Switching to a Biosimilar

  • May 7 2024
  • Duración: 38 m
  • Podcast

Episode 103: Switching to a Biosimilar  Por  arte de portada

Episode 103: Switching to a Biosimilar

  • Resumen

  • Since a number of biosimilars to Humira became available in 2023, many more arthritis patients have become aware of these drugs, and many are being required by insurance to switch to one. In this episode, a patient and a rheumatologist will discuss their experience with biosimilars and how they are addressing concerns. *Visit the Live Yes! With Arthritis Podcast episode page to get show notes, additional resources and read the full transcript: https://arthr.org/LiveYes_Ep103 (https://arthr.org/LiveYes_Ep103) * We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing podcast@arthritis.org (podcast@arthritis.org). Special Guests: Dr. Angus Worthing and Rick Phillips.
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Episode 103: Switching to a Biosimilar

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.